Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Larry,
So very well said, that deserves an Amen!
mcd
Poker, thanks for listening. I thought you didn't agree with Steve and I wasn't sure how respected of an analyst he is. Hope it was worth your time.
I don't have a wave count but think there will be another leg up trying to support BO's election and trying to get more retail buyers to become bagholders.
mcd
Poker,
Yesterday on Market Wrap with Moe Ansari, he had a discussion with Steve Hochberg, Chief Market Analyst at Elliott Wave International
The interview was at about 25-30 minutes into the show. Just curious of what you thought of Steve's EW analysis.
mcd
http://marketwrapwithmoe.com/podcast
Glen, your down call for next week goes along with the max pain for SPY being 119.0.
http://www.optionpain.com/OptionPain/Option-Pain.php
This may increase the odds that tomorrow is a down day.
Called the Buffett Rule, the proposal will be part of a comprehensive deficit reduction plan that President Barack Obama will unveil on Monday,
http://www.cnn.com/2011/POLITICS/09/18/obama.buffett.tax/index.html?hpt=hp_t1
Seems like when Obama speaks lately, Wall Street, investors, and Business people like to express their disapproval by selling stocks.
mcd
Foot,
Geat board! I enjoy learning from you all.
On your 10 year treasuries chart, looks like stocks turn about 2 - 3 months after the treasuries turn. If so, treasuries still going down so stocks still have much more down to go.
Would an announcement like QE3 violate this lagged relationship?
mcd
BT,
The rising ATR doesn't look to be true from late Dec to late Feb?
Market went up.
BT,
Do you take notice of the "max pain" number for spy options to see if that lines up with where you see the market going by the end ofthis week / option expiration?
mcd
Thanks for the reply. I had wondered if the initial move down this morning might be the move on down to the lower border. Will be watching for more up before the down move.
BT,
Just didn't want you to think you were alone here.
So do you think it is headed for the 1295-1300 area and then evaluate if a bounce is still in order?
mcd
Blasher,
"Let me know what I need to do as moderator"....is that what you really meant?
The board should have never been allowed to get so far off topic. It is impossible not to have an off topic comment here and there, but rants and diatribes, obviously meant to provoke others, should not be allowed.
I hope the board can recover but we DON'T need anyone to post a youtube music video of "The Way We Were"......that is also off topic.
The potential short squeeze above 1131 would be there time sell, maybe.
I think they will bounce it up. The Jobs Report was more of the normal bad and not the surprisingly bad needed to start NM's cascading waterfall. Or NOT, of course.
We need a Target from Glen.
I think NM is probably right, they GAP Down on the headline numbers then bring it back up talking about the improvement in Avg Hourly Earning and Avg Weekly Hours, and that -131k is better than the -221k last month.
All spin from the Boyz.
On the daily chart, Doesn't it look like the Q's are ready to bounce off of the 20 MA, the 50 MA and an uptrend line? 20 MA is moving up through the 50.
Just a guess, that the Govt.'s manufactured good news of the Euro stress tests will be enough to blast through rez up to 1115, then drop back to 1094ish to close. That would give YRT1 his shooting star candle, or maybe NOT!
Thanks for the response. I just see all that as misleading and not an area where we should be looking for answers. There are billions of heavenly bodies in the universe. I'm sure astrologers could find some to correlate to almost anything for a given period of time. Any pattern will become temporary given enough time. It might seem to work until it doesn't. To me, that means it doesn't really work.
mcd
You, Personally I don't believe that there is any actual relationship between the alignment of planets and with buying and selling in the stock market, except that the people who believe that may create some buying and selling demand. How many people do you think trade stocks based on the cosmos?
How could a revolution be predicted in America as opposed to some other country. If the calculations were off by a moon or two then the revolution in the USA might instead be a revalation in Uraguay?
What weight do you put on this type information vs. TA, ewave, etc.
mcd
With news stories like this, are the Boyz just trying to nurse this rally through Friday? Then maybe the trap door opens.......
http://finance.yahoo.com/banking-budgeting/article/110070/the-big-mo?mod=bb-budgeting&sec=topStories&pos=1&asset=&ccode=
mcd
Do any of you follow this "guru", Jon Johnson at InvestmentHouse.com
http://www.investmenthouse.com/weekendmarketsummary.htm
He also has a technical analysis video.
You,
So tomorrow you think S&P goes from 1050ish to 1009ish?
Are you opening short positions this afternoon?
mcd
Glen,
I agree totally. Thanks for your comments. I always appreciate your insights and wisdom. Many people are seeing through a veil.
mcd
Glen,
Do you think we will repeat June 3rd thru 8th?
mcd
Foot,
From looking at that chart, do you think the euro has been trending with the SPX or even a slight leading indicator for SPX? If true, is the euro foretelling a major decline in SPX, or has that relationship been broken?
mcd
I heard on TV that BO was going back down there to show he could be more personable. He was planning to touch a few people and hug some people. What a joke! Is that something you plan before going down there? Hopefully someone will charge him with sexual harrassment.
mcd
Gold,
So are you admitting that you jumped to the extreme negative conclusion when you stated "this is standard PR for a company like BioCurex that is going to have a booth in the exhibit hall."
Or that you made a negative determination before you read the PR clearly or had the facts?
mcd
Gold,
You stated "this is standard PR for a company like BioCurex that is going to have a booth in the exhibit hall."
How can you say that when the announcement says "Chairman Denis Burger is scheduled to present on behalf of the Company on Thursday, May 6, 2010 at 11:15 a.m. in Presentation Room 1."
Are you saying the company is grossly exagerating what Burger will be doing? Is an exibit hall also known as a presentation room? I don't think so.
mcd
Talk about Govt waste..........
On your lunch break today, in honor of the Fed, BO, and Pelosi take a look at this classic video by Tim Hawkins.
Half,
It looks to me that it is specific to two types. That at least is more definitive than Recaf indicating that you may have some/all types of cancer.
My point is that BRCA may be used because it tells you that you are disposed to a specific type of cancer. So doctors can use the test in specific circumstances.
Recaf for screening tells you that you're positive for some "non-specific" cancer. The use of recaf needs to be boiled down to a specific use such as monitoring, where the doctor knows the likely cancer type if the reading is positive.
mcd
Half,
Why do you consider BRCA a universal marker?
"A BRCA gene test does not test for cancer itself. This test is only done for people with a strong family history of breast cancer or ovarian cancer, and sometimes for those who already have one of these diseases."
It test for something specific. That is not the same as RECAF.
mcd
IMO, Moro has the cart before the horse now in trying to push Oncopet to the investing community. He needs to publicize it to the pet owners who would ask their vets for the test to be performed. That's why drugs are marketed on tv commercials so patients will ask their doctor for the meds. Moro should be trying to get the word out. Creating a website and issuing a press release to investors isn't creating any demand for the product. Moro seems more concerned about creating demand for the stock than he does about the product.
mcd
BioCurex Announces Effectiveness of a $6 Million Public Offering
Buzz up! 0 Print
Press Release Source: BioCurex, Inc. On Tuesday January 19, 2010, 12:17 pm
RICHMOND, British Columbia, Jan. 19, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX - News) announced today that its registration statement covering the sale of 1.2 million units has been declared effective by the U.S. Securities and Exchange Commission. The public offering price of the units is $5.00 per unit, each consisting of 70 shares of the company’s common stock and 70 five-year redeemable common stock purchase warrants, or 84,000,000 shares and 84,000,000 warrants in the aggregate. The shares and the warrants included in the units will be quoted separately on the Over-the-Counter Bulletin Board under the symbols BOCX and BOCXW, respectively. Trading in the warrants is subject to clearance by the Bulletin Board, which is expected by January 20, 2010. The managing underwriter of the offering is Paulson Investment Company, Portland, Oregon. The closing of the offering is expected to occur on Friday, January 22, 2010.
Securities Law Disclaimer
A registration statement relating to the securities described in this press release has been declared effective by the U.S. Securities and Exchange Commission. The securities may not be sold or offered in any state unless the offer and sale of such securities has been qualified in such state. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in the registration statement. Such offer to sell or solicitation of an offer to buy may only be made by a prospectus. If you would like to receive a copy of the prospectus relating to the offering, please contact Paulson Investment Company, Inc., 811 SW Naito Parkway, Portland, Oregon 97204, 503-243-6000.
Forward Looking Statement Disclaimer
This release contains a number of forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company’s actual operating results to be materially different from any historical results or from any future results expresses or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “believes,” “belief,” “expects,” “expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans” and “plan,” to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with Securities and Exchange Commission. Since these statements involve risks and uncertainties and are subject to change at any time, the Company’s actual results could differ materially from expected results. The forward looking statements in this press release include statements regarding trading in the company’s securities and the anticipated closing date of the offering.
Communications Act Disclaimer:
The Company has not authorized the release of this information in any form that contravenes the Communication Act and will not be responsible for unsolicited massive distribution of this material by e-mail or facsimile by unauthorized parties.
About BioCurex
BioCurex is a development stage diagnostics company focusing on development and commercialization of products for the early detection, diagnosis, and monitoring of recurrence of cancer. BioCurex has developed a blood test, Serum-RECAF™ that can detect the presence of cancer in humans and companion animals using a new cancer marker named RECAF™. The company’s web site is available at www.biocurex.com.
Contact:
BioCurexRicardo Moro(604) 207-9150AGORACOM Investor Relationsbocx@agoracom.comhttp://www.agoracom.com/ir/biocurex Buzz up! 0 SendSharePrint
Goldseeker said, "There would be no royalty payment from Inverness until December 2010. There would be no reason whatsoever for Inverness to effect a product return until 30 days prior to the anniversary of the effective date of the license, or November 4, 2010. "
My understanding is that Inverness will owe Biocurex the royalty payment for this next year unless they initiated a product return before 11/4/2009. Not 2010. It may be true that Biocurex will not receive the payment until Dec. 2010, but the deciding factor has already ocurred.
Are you saying that Inverness has another year to determine whether they allow the royalty payment to take effect?
mcd
Gyro,
I don't think theBocx had a well coming in. That was Lawman or Dog. I also wondered what happened to him.
mcd
Gaboy, thanks, I try to remember that there is always two sides to the story.
GS stated, What should concern you is the shorting of the stock back down to the 14 cent area of Smithlines note conversion price.
Do you see a possibility that Inverness pays the royalty, the share price goes up, and Smithline becomes a little more patient in converting shares (if they are actually converting shares), and BOCX raises funds at a higher share price?
mcd
GS,
I have to say that, IMO, I do agree with other posters that you have gone from seeing all positives with BOCX to seeing all negatives. You do develop theories which you present as the only possible explanation. Lately, they always emphasize the nagative.
That's just how I see it.
I do agree that it seems strange why Dr. Moro would try to raise $6 million at this low share price. If Inverness makes the milestone payment, even if they don't say a word about progress and say nothing publicly, the share price of BOCX should go up. It will be a relief just to know Inverness is still working with Recaf towards a product. Placing shares should be much easier with a positive sign from Inverness. The boost in the share price could even save shareholders 50-100,000,000 shares of dilution. That would make a huge difference to the share price if/when BOCX has earnings per share.
Tell me if this is correct. The shares need to be authorized next week. The Inverness milestone payment is due or must be notified of intent in the November/December time frame. This could still happen before the new shares are placed. If this works out in BOCX's favor, BOCX could raise the funds needed at a higher share price and not place all of the authorized shares.
mcd
Gaboy,
I agree with you more than you realize. I am suspicious of people's motivations as well. I was once extremely hopeful for Recaf and this stock. I was so bullish that I allowed myself to get too heavily invested in this one stock. As the share price dropped, I stayed too long and lost too much. Sure, I could have held on and would still be waiting to recoop my initial investment. I think my average share price was in the .60's.
During the time that I was extremely bullish, I was like you and felt I was needing to help Dr. Moro get the word out about BOCX. I e-mailed cancer organizations and support groups. I put messages on the Abbott and Dendreon message boards. I did what I could. Dr. Moro was making advancements with the technology and test formats, but nothing ever seemed to get any traction. I eventually got frustrated with the lack of tangible results from Dr. Moro's hopeful PR's. While I owned the stock, I think I let hope for success cloud my judgement and not see the negatives. Now I see the positives and negatives and I admit that I don't know which way it will turn out. I recently bought back a few shares just in case Inverness makes the milestone payment.
I hope Dr. Moro is able to raise the funds needed. I do wonder why Dr. Moro would try to raise enough money for two years operations and create huge dilution at this share price. Why not raise enough money to pay off Smithline and operate for a short time. If Inverness makes the milestone payment, the share price should get a boost, Smithline would be out of our hair and, I would think that Dr. Moro could then easily place shares at a higher price. Is Dr. Moro thinking that revenues from oncopet and any progress from Inverness is still more than a year away?
mcd
Gaboy,
You are mistaken about me. You were confused about the conversion of shares and I was just trying to help.
Not sure why you think I am a GS cheerleader?
I agree that it does make more sense for Smithline to be selling. But I have no idea who is selling.
You shouldn't be so snappy to a fellow GA boy.
mcd